Affimed (NASDAQ:AFMD) is set to announce its earnings results before the market opens on Tuesday, March 20th. Analysts expect the company to announce earnings of ($0.19) per share for the quarter.

Shares of Affimed (NASDAQ:AFMD) traded up $0.02 on Wednesday, hitting $2.22. 253,921 shares of the stock traded hands, compared to its average volume of 912,506. The firm has a market cap of $126.39, a PE ratio of -2.82 and a beta of 2.25. The company has a debt-to-equity ratio of 0.14, a current ratio of 6.43 and a quick ratio of 6.39. Affimed has a 12 month low of $1.15 and a 12 month high of $2.85.

How to Become a New Pot Stock Millionaire

Separately, Oppenheimer reaffirmed a “hold” rating on shares of Affimed in a research note on Friday, November 24th.

ILLEGAL ACTIVITY WARNING: “Affimed (AFMD) Set to Announce Earnings on Tuesday” was originally reported by Daily Political and is the sole property of of Daily Political. If you are accessing this article on another site, it was illegally stolen and republished in violation of United States and international copyright & trademark law. The legal version of this article can be read at https://www.dailypolitical.com/2018/03/14/affimed-afmd-set-to-announce-earnings-on-tuesday.html.

About Affimed

Affimed N.V. is a clinical-stage biopharmaceutical company focused on discovering and developing cancer immunotherapies. The Company’s product candidates are developed in the field of immuno-oncology, which represents an approach to cancer research that seeks to harness the body’s own immune system to fight tumor cells.

Earnings History for Affimed (NASDAQ:AFMD)

Receive News & Ratings for Affimed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Affimed and related companies with MarketBeat.com's FREE daily email newsletter.